Abstract:Lissencephaly is a developmental cortical malformation characterized by reduced to absent gyri and a disorganized cortex, often leading to severe impairments in affected individuals and a reduced life expectancy. Heterozygous mutations in the gene, encoding a regulator of the microtubule motor dynein, cause lissencephaly with different clinical severities. While the clinical disease spectrum correlates with the degree of lissencephaly, location and type of mutation may not. We leveraged forebrain-type organoids from LIS1-lissencephaly patients, diagnosed with mild, moderate or severe lissencephaly to investigate, in a cytoarchitecture and multi-omics approach, how the severity degree in patients might relate to specific mutations in the gene. We questioned which processes during cortical development might be differentially affected by severity grade, and whether they could be pharmacologically targeted. We found alterations in neurodevelopment often with a severity- dependent gradient. Specifically, we identified alterations of the cytoarchitecture, progenitor cell homeostasis and neurogenesis. Particularly important disease-linked molecular mechanisms were microtubule destabilization, WNT-signaling, and perturbed cadherin- and unfolded protein-binding. Some mechanisms exhibited a severity-dependent gradient, or were specific to a severe grade. We present strategies to reverse phenotypic changes in LIS1- patient organoids, and an approach with therapeutic potential. Thus, we show that different LIS1-severity grades can be recapitulated , that there is a direct link between the phenotype and genotype, that organoid-based disease modeling can identify molecular underpinnings of malformations of cortical development and that organoids provide a valid platform to develop and test therapeutic strategies.

Novel lissencephaly-associated NDEL1 variant reveals distinct roles of NDE1 and NDEL1 in nucleokinesis and human cortical malformations

Human mutations in NDE1 cause extreme microcephaly with lissencephaly [corrected]

[Microlissencephaly due to pathogenic variants of NDE1: from pathology to normal brain development]

NDE1‐related disorders: A recurrent NDE1 pathogenic variant causing Lissencephaly 4 can also be associated with microhydranencephaly

Opposing Effects of Ndel1 and Α1 or Α2 on Cytoplasmic Dynein Through Competitive Binding to Lis1

Severe NDE1-mediated microcephaly results from neural progenitor cell cycle arrests at multiple specific stages

Prenatal Phenotypic Expansion: A Fetus with Neurodegeneration with Developmental Delay, Early Respiratory Failure, Myoclonic Seizures, and Brain Abnormalities (NDDRSB) and MED11 Variants.

The essential role of centrosomal NDE1 in human cerebral cortex neurogenesis

Loss of symmetric cell division of apical neural progenitors drives -related developmental and epileptic encephalopathy

Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy

Deletion 16p13.11 uncovers NDE1 mutations on the non-deleted homolog and extends the spectrum of severe microcephaly to include fetal brain disruption

Nde1 is required for heterochromatin compaction and stability in neocortical neurons

NDE1 and NDEL1 from genes to (mal)functions: parallel but distinct roles impacting on neurodevelopmental disorders and psychiatric illness

Multiple dose-dependent effects of Lis1 on cerebral cortical development

Unraveling LIS1-Lissencephaly: Insights from Cerebral Organoids Suggest Severity- Dependent Genotype-Phenotype Correlations, Molecular Mechanisms and Therapeutic Strategies

Severe congenital microcephaly with 16p13.11 microdeletion combined with NDE1 mutation, a case report and literature review

Dlic1 Deletion Impaired Cerebellar Development in Mouse

Variations pathogènes de NDE1 et microlissencéphalie

Lis1-Nde1-dependent neuronal fate control determines cerebral cortical size and lamination

Novel syndromic neurodevelopmental disorder caused by de novo deletion of , a long noncoding RNA

A Homozygous Variant in INTS11 Links Mitosis and Neurogenesis Defects to a Severe Neurodevelopmental Disorder